Sculptor Capital’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$426M Buy
24,000,000
+2,282,272
+11% +$36M 3.47% 4
2026
Q1
$311M Buy
21,717,728
+717,728
+3% +$11.9M 3.24% 6
2025
Q4
$370M Buy
21,000,000
+7,658,200
+57% +$127M 3.81% 3
2025
Q3
$210M Buy
13,341,800
+1,841,800
+16% +$25.9M 2.48% 5
2025
Q2
$128M Buy
11,500,000
+2,462,489
+27% +$28.8M 1.8% 7
2025
Q1
$105M Buy
9,037,511
+4,037,511
+81% +$52M 2.01% 9
2024
Q4
$68.4M Buy
+5,000,000
New +$72.5M 0.91% 27

Other funds holding SHC

Sculptor Capital's SHC Position: Q2 2026 in Review

Sculptor Capital increased its Sotera Health (SHC) stake by 11% in Q2 2026, buying an estimated $36M and bringing the position to 24,000,000 shares worth $426M. The position accounts for 3.47% of the portfolio, ranked #4.

Sculptor Capital first reported a position in SHC in Q4 2024 and has held it in 7 quarters since. 319 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Sculptor Capital held 24,000,000 shares of Sotera Health worth $426M as of Q2 2026.
  • Sculptor Capital bought 2,282,272 Sotera Health shares in Q2 2026, an estimated $36M.
  • Sotera Health made up 3.47% of Sculptor Capital's portfolio in Q2 2026, its #4 holding.
  • Sculptor Capital first reported a position in Sotera Health in Q4 2024 and has held it in 7 quarters since.
  • 319 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Sculptor Capital's 13F filing for Q2 2026, filed 14 Aug 2026.